G&E Herbal Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 40.77 million compared to TWD 7.25 million a year ago. Net income was TWD 15.06 million compared to net loss of TWD 5.01 million a year ago.

Basic earnings per share from continuing operations was TWD 0.27 compared to basic loss per share from continuing operations of TWD 0.09 a year ago.